Announcements Trials
Browse Landscape

Phase

Phase 2 57Phase 1/2 17Phase 1 16Phase 3 4Phase NA 2Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2

Conditions

Lymphoma 18Lymphoma, Large B-Cell, Diffuse 12Lymphoma, Non-Hodgkin 9Lymphoma, B-Cell, Marginal Zone 4Leukemia 4Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Hodgkin Disease 3Waldenstrom Macroglobulinemia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Nausea 2Leukemia, Lymphocytic, Chronic, B-Cell 2Vomiting 1Orbital lymphoma 1Myelodysplastic Syndromes 1Myasthenia Gravis 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Immunoblastic Lymphadenopathy 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1

Interventions

Peripheral Blood Stem Cell Transplantation 7fludarabine phosphate 6Whole-Body Irradiation 6Cyclosporine 5Mycophenolic Acid 4Melphalan 3Filgrastim 3Etoposide 3Busulfan 3Blood Specimen Collection 3Antilymphocyte Serum 3Rituximab 2Methotrexate 2Granulocyte Colony-Stimulating Factor 2Carmustine 2zanubrutinib 1thymoglobulin 1plerixafor 1amuvatinib 1Transplantation 1Thiotepa 1Therapeutics 1Tacrolimus 1Radiotherapy 1Pentetic Acid 1Palliative Care 1Oxycodone 1Ondansetron 1O(6)-benzylguanine 1Nutritional Support 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Waldenstrom Macroglobulinemia × Rituximab × Clear all
NCT06942507 2025-04-30

BRZ-WM

Peking Union Medical College Hospital

Phase NA Not yet recruiting
104 enrolled
Lymphoid

Waldenstrom Macroglobulinemia

NCT00142155 2011-06-27

Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia

Dana-Farber Cancer Institute

Phase NA Completed
300 enrolled
Lymphoid

Waldenstrom Macroglobulinemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡